Physician profile
Amit Agarwal
NPI 1427097211
$5,811.89
in general payments reported to CMS, 2019-2025
46 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $329 · 2021: $860 · 2022: $800 · 2023: $1,503 · 2024: $507 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,086.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $767.01 | 2019-2023 | Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $356.96 | 2023-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $331.50 | 2020-2022 | |
| Astrazeneca Pharmaceuticals Lp | $328.14 | 2019-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $325.11 | 2021-2025 | Zepbound, Mounjaro, Kisunla |
| Neurocrine Biosciences, INC. | $311.52 | 2022 | |
| Abiomed | $304.63 | 2023-2024 | Impella |
| Bausch Health US, LLC | $283.90 | 2021-2025 | Aplenzin, Wellbutrin |
| Janssen Pharmaceuticals, INC | $278.37 | 2019-2023 | Xarelto |
| Acadia Pharmaceuticals INC | $255.28 | 2021-2023 | Nuplazid |
| Novo Nordisk INC | $252.85 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $221.12 | 2021-2025 | |
| Boston Scientific Corporation | $184.92 | 2019-2025 | Avvigo Guidance System, Watchman Access System |
| Abbvie INC. | $152.28 | 2022 | |
| Qapel Medical INC | $147.27 | 2024 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.